SWITCH Biotech AG utilizes its broad knowledge of the molecular biology of the skin to develop drugs for skin disorders. To this end, partnerships for various business opportunities are offered.
SWITCH Biotech applies its comprehensive functional genomics platform to discover and develop personalized medicine and mechanism-based drugs that treat dermatological diseases and conditions.
R&D
To view this information, you must subscribe to PL Intelligence.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Deals
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Board of directors
To view this information, you must subscribe to PL Intelligence.
Contact details
To view this information, you must subscribe to PL Intelligence.
All rights reserved. Terms and Conditions | Contact us
